1Woodle ES,Vincenti F,Lorber MI,et al.A multicenter,open label pi-lot study of early corticosteroid cessation in de novo renal transplant re-cipients under basiliximab,tacrolimus and sirolimus therapy[].American Journal of Transplantation.2003
2Bustami RT,Ojo AO,Wolfe RA,et al.Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients[].American Journal of Transplantation.2004
3Flechner SM,Kurian SM,Solez K,et al.De novo kidney transplanta-tion without use of calcineurin inhibitors preserves renal structure and function at two years[].American Journal of Transplantation.2004
4McTaggert RA,Tomlanovich S,Bostrom A,et al.Comparsion of out-comes after delayed graft function:sirolimus-based versus other calci-neurin-inhibitor sparing induction immunosuppression regimens[].Transplantation.2004
5Jackson SH,Yu CR,Mahdi RM,et al.Dendritic cell maturation requires STAT1and is under feedback regulation by suppressors of cytokine sig-naling[].J Immunol.2004
6Stepkowski SM,Kao J,Wang ME,et al.The mannich base NC1153promotes long-term allograft survival and spares the recipient from multiple toxicities[].J Immunol.2005
7Abramson LP,Pahl E,Huang L,et al.Serum vascular endothelialgrowth factor as a surveillance marker for cellar rejection in pediatric cardiac transplantation[].Transplantation.2002
8Gabardi S,Cerio J.Future immusuppressive agents in solid-organ transplantation[].Progress in Transplantation.2004
9Crippin JS.What′s new-what′s hot in clinical science:American Transplant Congress2004[].American Journal of Transplantation.2004
10Valente,JF,Hricik,D,Weigel,K,Seaman,D,Knauss,T,Siegel,CT,Bodziak,K,Schulak,JA.Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation[].American Journal of Transplantation.2003
